Eligibility Lung Neoplasms NCT00157209

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
stage iiib or stage iv nsclc
Descrizione

NSCLC staging

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0278984
UMLS CUI [2]
C0278987
stable disease or a clinical response following first-line treatment, consisting of either chemotherapy alone or chemotherapy and radiotherapy. patients must have completed the first-line treatment at least 3 weeks prior to study entry
Descrizione

Treatment details

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1704632
UMLS CUI [2]
C1708063
UMLS CUI [3]
C0392920
UMLS CUI [4]
C3839414
UMLS CUI [5]
C0580352
ecog performance status of ≤2
Descrizione

ECOG performance status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
ability to understand and willingness to sign a written informed consent
Descrizione

Informed consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
received immunotherapy within 4 weeks prior to study entry
Descrizione

Immunotherapy: date

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021083
UMLS CUI [2]
C2584899
received immunosuppressive drugs within 3 weeks prior to study entry
Descrizione

Immunosupression: date

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0021079
UMLS CUI [1,2]
C2584899
patients with known brain metastases
Descrizione

Brain metastases

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0220650
past or current history of neoplasm other than lung carcinoma, except for curatively treated non-melanoma skin cancer, in situ carcinoma of the cervix or other cancer curatively treated and with no evidence of disease for at least 5 years
Descrizione

Further malignancies

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0332196
UMLS CUI [1,3]
C0007114
UMLS CUI [2,1]
C0006826
UMLS CUI [2,2]
C0332196
UMLS CUI [2,3]
C2216722
UMLS CUI [3,1]
C0006826
UMLS CUI [3,2]
C0332196
UMLS CUI [3,3]
C0242793
autoimmune disease or immunodeficiency
Descrizione

Autoimmune disease or immunodeficiency

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0004364
UMLS CUI [2]
C0021051
clinically significant hepatic, renal or cardiac dysfunction
Descrizione

Liver, renal and cardiac function

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C0232804
UMLS CUI [3]
C0232164
patients with clinically significant active infection
Descrizione

Infection

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0009450
pregnant or breast feeding women, women of childbearing potential, unless using effective contraception as determined by the investigator
Descrizione

Gynaecological status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C3831118
UMLS CUI [3]
C0006147
UMLS CUI [4]
C0700589

Similar models

Eligibility Lung Neoplasms NCT00157209

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
NSCLC staging
Item
stage iiib or stage iv nsclc
boolean
C0278984 (UMLS CUI [1])
C0278987 (UMLS CUI [2])
Treatment details
Item
stable disease or a clinical response following first-line treatment, consisting of either chemotherapy alone or chemotherapy and radiotherapy. patients must have completed the first-line treatment at least 3 weeks prior to study entry
boolean
C1704632 (UMLS CUI [1])
C1708063 (UMLS CUI [2])
C0392920 (UMLS CUI [3])
C3839414 (UMLS CUI [4])
C0580352 (UMLS CUI [5])
ECOG performance status
Item
ecog performance status of ≤2
boolean
C1520224 (UMLS CUI [1])
Informed consent
Item
ability to understand and willingness to sign a written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Immunotherapy: date
Item
received immunotherapy within 4 weeks prior to study entry
boolean
C0021083 (UMLS CUI [1])
C2584899 (UMLS CUI [2])
Immunosupression: date
Item
received immunosuppressive drugs within 3 weeks prior to study entry
boolean
C0021079 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
Brain metastases
Item
patients with known brain metastases
boolean
C0220650 (UMLS CUI [1])
Further malignancies
Item
past or current history of neoplasm other than lung carcinoma, except for curatively treated non-melanoma skin cancer, in situ carcinoma of the cervix or other cancer curatively treated and with no evidence of disease for at least 5 years
boolean
C0006826 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0007114 (UMLS CUI [1,3])
C0006826 (UMLS CUI [2,1])
C0332196 (UMLS CUI [2,2])
C2216722 (UMLS CUI [2,3])
C0006826 (UMLS CUI [3,1])
C0332196 (UMLS CUI [3,2])
C0242793 (UMLS CUI [3,3])
Autoimmune disease or immunodeficiency
Item
autoimmune disease or immunodeficiency
boolean
C0004364 (UMLS CUI [1])
C0021051 (UMLS CUI [2])
Liver, renal and cardiac function
Item
clinically significant hepatic, renal or cardiac dysfunction
boolean
C0232741 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
C0232164 (UMLS CUI [3])
Infection
Item
patients with clinically significant active infection
boolean
C0009450 (UMLS CUI [1])
Gynaecological status
Item
pregnant or breast feeding women, women of childbearing potential, unless using effective contraception as determined by the investigator
boolean
C0032961 (UMLS CUI [1])
C3831118 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
C0700589 (UMLS CUI [4])